QR Code

VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS

Vaccination against pneumococcal infections by 13-valent conjugate vaccine (PCV13) can significantly reduce morbidity and mortality.The study has been aimed to evaluate the social and pharmacoeconomic aspects of PCV13 vaccination of 65-year-old patients with various risks of pneumococcal infection.M...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: A. V. Rudakova, N. I. Briko, Yu. V. Lobzin, L. S. Namazova-Baranova, S. N. Avdeev, G. L. Ignatova, M. P. Kostinov, I. S. Koroleva, R. V. Polibin, I. V. Fomin
Hōputu: Artigo
Reo:Russo
I whakaputaina: Journal Infectology 2018-10-01
Rangatū:Журнал инфектологии
Ngā marau:
pneumococcal infections
prevention
adults
pneumococcal conjugate vaccine
cost effectiveness
budget impact
Urunga tuihono:https://journal.niidi.ru/jofin/article/view/752
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite